Hendrix Genetics is a leading multi-species animal breeding company with primary activities in layer-, turkey-, traditional poultry-, swine-, trout, and salmon breeding. Backed by a strong portfolio of leading brands, Hendrix Genetics provides expertise and resources to producers in more than 100 countries, with operations and joint ventures in 24 countries and more than 2.880 employees worldwide. Creating value with genetics is the essence of their existence. The three key components of how they create value for the animal protein chain are: collaboration, innovation, and sustainability. They see collaboration as a key factor in continuing to improve their products in the right way, as well as evolving towards co-creation of genetic solutions – not only with their current partners but with those across the value chain, including feed, pharma, and equipment companies. They believe in the power of long-term partnerships with their customers and suppliers. Innovation is at the core of their strategy. This is why they invest so much into the development of their breeding animals. Through their research, they continuously improve the various aspects of their genetics, focusing on new technologies and smarter and new applications of existing technologies. They are constantly seeking new ideas through open innovation with partners focusing on entirely different technologies or industries. As a third component, they understand that sustainable production is inextricably linked to a sustainable value chain. They believe that their sustainability program – based on the three priority areas of Animals, People, and Planet – can play a key part in achieving sustainability. At Hendrix Genetics, they help the world meet the growing demand for food by supporting the animal protein value chain with innovative and sustainable genetic solutions. Their ambition is to create value through Better Breeding Today for a Brighter Life Tomorrow. Founded in 2005 and headquartered in The Netherlands, their last Private Equity Round investment took place on 22 November 2021, with investment from Paine Schwartz Partners, Rabo Investments, Mitsui & Co.
No recent news or press coverage available for Hendrix Genetics.